City Therapeutics, Inc.
IPO of $200M

IPO of $200M
Undisclosed of $40.7M
IPO of $150M
Undisclosed of $7.3M
Undisclosed of $55.0M
Undisclosed of $7.5M
Undisclosed of $49.8M
FDA goal date for Phentolamine Ophthalmic Solution 0.75% (sNDA), for presbyopia
Change in directors or officers
Change in directors or officers
Change in directors or officers
Change in directors or officers
Change in directors or officers
Change in directors or officers
Change in directors or officers
Change in directors or officers
Change in directors or officers
Change in directors or officers
Change in directors or officers
Change in directors or officers
Change in directors or officers